The following license files are associated with this item:
- QMRO Home
- William Harvey Research Institute
- Centre for Biochemical Pharmacology
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Browse
Administrators only